Aequs Ltd has announced a preferential issue of over 2.8 crore convertible warrants to its promoter, Mellwood Trustee Services Private Limited, at Rs 231.55 per unit. This Rs 650 crore capital infusion is earmarked for aerospace capacity expansion, joint venture investments, and working capital needs. The move increases promoter shareholding from 59.09% to 60.73% and highlights a strategic focus on scaling global operations and fulfilling a $1 billion aerospace order book.
Aequs Ltd Announces Rs 650 Crore Capital Infusion via Warrants
Total Issue Size: INR 649,999,819.50 | Warrant Price: INR 231.55 per unit
Reader Takeaway: Promoter-led capital injection supports aggressive aerospace expansion; monitoring agency CARE Ratings ensures transparent fund utilization.
What just happened
Aequs Ltd is set to conduct an Extraordinary General Meeting (EGM) on October 22, 2026, to seek shareholder approval for a preferential issue of 28,071,690 convertible warrants. The warrants will be issued to promoter entity Mellwood Trustee Services Private Limited at an issue price of Rs 231.55, which includes a premium of Rs 221.55. Subscribers are required to pay 50% upfront, with the remainder due upon exercise of the warrants by December 31, 2027.
Strategic Rationale
The company intends to utilize the proceeds to strengthen its balance sheet and operational capacity. The deployment plan includes Rs 289 crore for capital expenditure, Rs 100 crore for joint ventures, Rs 100 crore for working capital, and Rs 161 crore for general corporate purposes. These investments are driven by a robust aerospace order book exceeding US$ 1 billion and the need to scale aero-engine and landing-gear production at its Hosur facility.
Governance and Monitoring
In compliance with SEBI ICDR regulations for issuances exceeding Rs 100 crore, Aequs has appointed CARE Ratings Limited as the monitoring agency. This body will oversee the utilization of the Rs 650 crore proceeds, providing a layer of accountability for stakeholders. Following the full conversion of these warrants, the promoter group's equity stake in the firm is expected to climb to 60.73%, up from its current 59.09%.
What to track next
Investors should closely watch the timeline for the Hosur facility capacity expansion. Progress in the aerospace segment and the company’s ability to convert its US$ 1 billion order book into recognized revenue will be the primary drivers of future value. Additionally, adherence to the deployment schedule as monitored by CARE Ratings will remain a focal point for institutional scrutiny.